UK markets open in 4 hours 43 minutes
  • NIKKEI 225

    29,068.63
    +517.70 (+1.81%)
     
  • HANG SENG

    25,330.96
    +368.37 (+1.48%)
     
  • CRUDE OIL

    82.66
    +1.35 (+1.66%)
     
  • GOLD FUTURES

    1,768.10
    -29.80 (-1.66%)
     
  • DOW

    35,294.76
    +382.20 (+1.09%)
     
  • BTC-GBP

    45,219.35
    +575.86 (+1.29%)
     
  • CMC Crypto 200

    1,464.06
    +57.32 (+4.07%)
     
  • ^IXIC

    14,897.34
    +73.91 (+0.50%)
     
  • ^FTAS

    4,123.97
    +16.09 (+0.39%)
     

Global Coronavirus Disease (COVID-19) Clinical Trials Report 2021: Overview of Trial Numbers and their Average Enrollment in Top Countries

·3-min read

Dublin, Oct. 12, 2021 (GLOBE NEWSWIRE) -- The "Coronavirus Disease 2019 (COVID-19) - Global Clinical Trials Review, H2, 2021" clinical trials has been added to ResearchAndMarkets.com's offering.

The clinical trial report provides an overview of Coronavirus Disease 2019 (COVID-19) Clinical trials scenario.

This report provides top line data relating to the clinical trials on Coronavirus Disease 2019 (COVID-19) . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.

Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope

  • the report provides a snapshot of the global clinical trials landscape

  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

  • the report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

  • the report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

  • the Report provides enrollment trends for the past five years

  • Report provides latest news for the past three months

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment

  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost

  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

  • Supports understanding of trials count and enrollment trends by country in global therapeutics market

  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Clinical Trials Report Coverage

  • Clinical Trials by Region

  • Clinical Trials and Average Enrollment by Country

  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific

  • Top Five Countries Contributing to Clinical Trials in Europe

  • Top Countries Contributing to Clinical Trials in North America

  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa

  • Top Five Countries Contributing to Clinical Trials in Central and South America

  • Clinical Trials by G7 Countries: Proportion of Coronavirus Disease 2019 (COVID-19) to Infectious Disease Clinical Trials

  • Clinical Trials by Phase in G7 Countries

  • Clinical Trials in G7 Countries by Trial Status

  • Clinical Trials by E7 Countries: Proportion of Coronavirus Disease 2019 (COVID-19) to Infectious Disease Clinical Trials

  • Clinical Trials by Phase in E7 Countries

  • Clinical Trials in E7 Countries by Trial Status

  • Clinical Trials by Phase

  • In Progress Trials by Phase

  • Clinical Trials by Trial Status

  • Clinical Trials by End Point Status

  • Subjects Recruited Over a Period of Time

  • Clinical Trials by Sponsor Type

  • Prominent Sponsors

  • Top Companies Participating in Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials

  • Prominent Drugs

  • Clinical Trial Profile Snapshots

Companies Mentioned

  • AstraZeneca Plc

  • Pfizer Inc

  • F. Hoffmann-La Roche Ltd

  • IQVIA Holdings Inc

  • PPD Inc

  • Novartis AG

  • GlaxoSmithKline Plc

  • Johnson & Johnson

  • Sorrento Therapeutics Inc

  • Eli Lilly and Co

For more information about this clinical trials report visit https://www.researchandmarkets.com/r/4lwsst

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting